Consensus Terns Pharmaceuticals, Inc.

Equities

TERN

US8808811074

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
4.91 ^USD	+5.82%		+7.68%	-24.35%

Apr. 10	Terns Pharmaceuticals, Inc. Appoints Melita Sun Jung as Chief Business Officer	CI
Mar. 27	UBS Trims Terns Pharmaceuticals Price Target to $18 From $19, Maintains Buy Rating	MT

Evolution of the average Target Price on Terns Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

3045f862a9a.Kqb4tZ-8AYq84UYdJWyKIbCsfpqvgpCP2JiBSBQxxu8.TNWo5a7NXtzzjStlQQDwR9rHL8r6x6G9tMvjG3ZL_4pr0r7T3tFu0NKREw~bb70a1c7c33077e10ba7f6b1315c7464

Analyst Recommendations on Terns Pharmaceuticals, Inc.

UBS Trims Terns Pharmaceuticals Price Target to $18 From $19, Maintains Buy Rating	Mar. 27	MT
JMP Securities Cuts Terns Pharmaceuticals Price Target to $15 From $17, Maintains Market Outperform Rating	Mar. 18	MT
BMO Capital Adjusts Price Target on Terns Pharmaceuticals to $19 From $18, Maintains Outperform Rating	Mar. 15	MT
Jefferies Adjusts Terns Pharmaceuticals Price Target to $22 From $18, Maintains Buy Rating	Jan. 18	MT
HC Wainwright Adjusts Price Target on Terns Pharmaceuticals to $5.50 From $8, Maintains Neutral Rating	Jan. 10	MT
Mizuho Adjusts Price Target on Terns Pharmaceuticals to $10 From $17, Maintains Buy Rating	Nov. 27	MT
HC Wainwright Adjusts Price Target on Terns Pharmaceuticals to $8 From $11, Keeps Neutral Rating	23-08-10	MT
Mizuho Ups Price Target on Terns Pharmaceuticals to $17 From $16, Keeps Buy Rating	23-08-09	MT
Mizuho Securities Initiates Terns Pharmaceuticals With Buy Rating, $16 Price Target	23-06-22	MT
Jefferies Initiates Terns Pharmaceuticals at Buy With $18 Price Target	23-06-07	MT
Roth MKM Initiates Terns Pharmaceuticals at Buy With $23 Price Target	23-05-31	MT
JPMorgan Adjusts Price Target on Terns Pharmaceuticals to $10 From $9, Maintains Neutral Rating	23-05-16	MT
BMO Capital Initiates Terns Pharmaceuticals at Outperform With $18 Price Target	23-05-08	MT
JPMorgan Adjusts Price Target on Terns Pharmaceuticals to $9 From $6, Maintains Neutral Rating	23-03-29	MT
HC Wainwright Adjusts Terns Pharmaceuticals' Price Target to $11 From $7, Keeps Neutral Rating	23-03-29	MT
JMP Securities Starts Terns Pharmaceuticals at Market Outperform With $17 Price Target	23-02-14	MT
UBS Initiates Coverage on Terns Pharmaceuticals With Buy Rating, $19 Price Target	23-02-07	MT
HC Wainwright Boosts Price Target on Terns Pharmaceuticals to $7 From $6, Maintains Neutral Rating	22-12-29	MT
Goldman Sachs Adjusts Price Target on Terns Pharmaceuticals to $14 From $9, Maintains Buy Rating	22-12-20	MT
Goldman Sachs Adjusts Price Target on Terns Pharmaceuticals to $9 From $4, Reiterates Buy Rating	22-09-28	MT
HC Wainwright Initiates Terns Pharmaceuticals at Neutral With $6 Price Target	22-09-12	MT
JPMorgan Downgrades Terns Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $6 From $19	22-03-23	MT
TERNS PHARMACEUTICALS : JPMorgan Starts Terns Pharmaceuticals at Overweight With $32 Price Target	21-03-02	MT
TERNS PHARMACEUTICALS : Cowen Initiates Coverage on Terns Pharmaceuticals With Outperform Rating	21-03-02	MT
TERNS PHARMACEUTICALS : Goldman Sachs Starts Terns Pharmaceuticals at Buy With $29 Price Target	21-03-02	MT